StockDuty ← Dashboard Sep 01, 2026 10:43 PM ET
SignalEU/UK

Roche Commits $75 Million in Blood-Cancer Deal Worth Up to $1.53 Billion

Roche Commits $75 Million in Blood-Cancer Deal Worth Up to $1.53 Billion

Roche Commits $75 Million in Blood-Cancer Deal Worth Up to $1.53 Billion
Roche Commits $75 Million in Blood-Cancer Deal Worth Up to $1.53 Billion — impact context not separately stored; see What changed.
Sources